Research

For full list of publications, check out my Google Scholar page.

Select Peer-reviewed Publications

  1. Whiting, K., Fei, T., Singer, S., & Qin, L. X. (2024). Cureit: An end-to-end pipeline for implementing mixture cure models with an application to liposarcoma data. JCO Clinical Cancer Informatics, 8, e2300234. 🔗
  2. Whiting, K., Guest, R., Seshan, V. E., & Kamboj, M. (2024). Susceptibility of healthcare personnel with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) hybrid immunity to XBB lineage reinfection. Infection Control & Hospital Epidemiology, 45(6), 781-784. 🔗
  3. Whiting, K., Robilotti, E. V. (co-first authors), Lucca, A., Poon, C., Jani, K., McMillen, T., Freeswick, S., et al. (2022). Effectiveness of mRNA booster vaccine among health care workers in New York City during the omicron surge, December 2021-January 2022. Clinical Microbiology and Infection. 🔗
  4. Whiting, K., Robilotti, E. V. (co-first authors), Lucca, A., Poon, C., Guest, R., McMillen, T., Jani, K., et al. (2021). Clinical and genomic characterization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in mRNA vaccinated health care personnel in New York City. Clinical Infectious Diseases. 🔗
  5. Whiting, K., Almassi, N. (co-first authors), Toubaji, A., Lenis, A. T., Jordan, E. J., Won, H., et al. (2022). Clinical and genomic characterization of bladder carcinomas with glandular phenotype. JCO Precision Oncology, 6, e2100392. 🔗
  6. Sjoberg, D. D., Whiting, K., Curry, M., Lavery, J. A., & Larmarange, J. (2021). Reproducible summary tables with the gtsummary package. R Journal, 13(1). 🔗
  7. Choudhury, N. J., Lavery, J. A., Brown, S., de Bruijn, I., Jee, J., et al. (2023). The GENIE BPC NSCLC cohort: A real-world repository integrating standardized clinical and genomic data for 1,846 patients with non-small cell lung cancer. Clinical Cancer Research. 🔗
  8. Lavery, J. A., Brown, S., Curry, M. A., Martin, A., Sjoberg, D. D., & Whiting, K. (2023). A data processing pipeline for the AACR project GENIE biopharma collaborative data with the {genieBPC} R package. Bioinformatics, 39(1), btac796. 🔗
  9. Necchi, A., Brembilla, G., Whiting, K., Arita, Y., Akin, O., Apte, A., Awais, M., et al. (2026). AI-MIRACLE: Artificial intelligence and multiparametric MRI predict clinical outcomes to neoadjuvant immunotherapy in patients with muscle-invasive bladder cancer undergoing radical cystectomy. European Urology Oncology, 9(4), 883-894. 🔗
  10. Funt, S. A., Lattanzi, M., Whiting, K., Al-Ahmadie, H., Quinlan, C., Teo, M. Y., et al. (2022). Neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with muscle-invasive bladder cancer: A multicenter, single-arm, phase II trial. Journal of Clinical Oncology, 40(12), 1312-1322. 🔗
  11. Chu, C. E., Chen, Z., Whiting, K., Ostrovnaya, I., Lenis, A. T., Clinton, T. N., Rammal, R., et al. (2025). Clinical outcomes, genomic heterogeneity, and therapeutic considerations across histologic subtypes of urothelial carcinoma. European Urology, 88(5), 472-481. 🔗
No matching items